Claudia Meek

Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability

Shashikant Srivastava, Jotam G. Pasipanodya, Claudia Meek et al. · The Journal of Infectious Diseases · 2011 · 270 citations · Full text

Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs

Tawanda Gumbo, Chandima S. W. Siyambalapitiyage Dona, Claudia Meek et al. · Antimicrobial Agents and Chemotherapy · 2009 · 192 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Antimicrobial Chemotherapy +18

The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance

Aurelia Schmalstieg, Shashikant Srivastava, Serkan Belkaya et al. · Antimicrobial Agents and Chemotherapy · 2012 · 191 citations · Full text

Antimicrobial Chemotherapy, Antibiotic Resistance, Drug Resistance +16

Efflux‐Pump–Derived Multiple Drug Resistance to Ethambutol Monotherapy in<i>Mycobacterium tuberculosis</i>and the Pharmacokinetics and Pharmacodynamics of Ethambutol

Shashikant Srivastava, Sandirai Musuka, Carleton M. Sherman et al. · The Journal of Infectious Diseases · 2010 · 128 citations · Full text

Effects of Atazanavir/Ritonavir or Fosamprenavir/Ritonavir on the Pharmacokinetics of Rosuvastatin

Anthony J. Busti, Amy M. Bain, Ronald G. Hall et al. · Journal of Cardiovascular Pharmacology · 2008 · 107 citations